Cited by 108Lipid metabolism and disordersDiabetes, Cardiovascular Risks, and LipoproteinsNutrition, Genetics, and Disease

The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.

Polymorphisms in the Fatty Acid-Binding Protein 2 and Apolipoprotein C-III Genes Are Associated with the Metabolic Syndrome and Dyslipidemia in a South Indian Population

Guettier, Jean-Marc, Georgopoulos, Angeliki, Tsai, Michael Y., Radha, Venkatesan, Shanthirani, Subramaniam, Deepa, Raj, Gross, Myron, Rao, Gundu, Mohan, Viswanathan·2005·The Journal of Clinical Endocrinology & Metabolism

DOI 10.1210/jc.2004-1338

Open this paper in CoChat — free account

Abstract

The Chennai Urban Population Study investigates a South Indian population with a high prevalence of cardiovascular disease associated with the metabolic syndrome (MS). The Ala54Thr polymorphism in the fatty acid-binding protein 2 (FABP2) gene as well as the T-455C and C-482T polymorphisms in the apolipoprotein C-III (APOC3) gene promoter have been associated with features of the MS in specific populations. This study evaluates in Asian-Indians the association between these polymorphisms with MS and dyslipidemia, defined according to National Cholesterol Education Program Adult Treatment Panel III. Allelic frequencies in 70 controls and 110 patients with diabetes from the Chennai Urban Population Study were 52.9% for FABP2 Thr54, 73.0% for APOC3 -482T, and 80.2% for APOC3 -455C. The polymorphisms were in agreement with Hardy-Weinberg equilibrium. Controls carrying FABP2 Thr54 were more likely to have MS than noncarriers (Fisher's exact test P = 0.031; odds ratio = 6.9 with a 95% confidence interval of 1.1, 43.9). Those carrying at least one polymorphic allele in both genes had a higher likelihood of having MS than wild type (Fisher's exact test P = 0.003; odds ratio = 12.1 with a 95% confidence interval of 1.88, 77.6). Dyslipidemia was associated with the polymorphism as well. The polymorphisms were not associated with MS in patients with diabetes. The association of the polymorphisms with MS and dyslipidemia could contribute to the high cardiovascular disease prevalence in this population.

Integrity signals

Registry

Crossref · 10.1210/jc.2004-1338

Cites

51 of 51 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,944
Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)
Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011
Statistical Methods for Rates and Proportions
Fleiss, J. L., Levin, B., & Paik, M. C. (2003) · Wiley Series in Probability and Statistics · doi:10.1002/0471445428 · Cited by 18,646
Statistical Methods for Rates and Proportions.
Everitt, B. S., & Fleiss, J. L. (1981) · Biometrics · doi:10.2307/2530193 · Cited by 9,034
The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men
Lakka, H.-M. (2002) · JAMA · doi:10.1001/jama.288.21.2709 · Cited by 5,033
Relation of central obesity and insulin resistance with high diabetes prevalence and cardiovascular risk in South Asians
McKeigue, P. M., Shah, B., & Marmot, M. G. (1991) · The Lancet · doi:10.1016/0140-6736(91)91164-p · Cited by 1,618
Differences in risk factors, atherosclerosis, and cardiovascular disease between ethnic groups in Canada: the Study of Health Assessment and Risk in Ethnic groups (SHARE)
Anand, S. S., Yusuf, S., Vuksan, V., Devanesen, S., Teo, K. K., Montague, P. A., Kelemen, L. E., Yi, C., Lonn, E., Gerstein, H. C., et al. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02502-2 · Cited by 1,060
Ethnic differences in mortality from ischaemic heart disease and cerebrovascular disease in England and Wales.
Balarajan, R. (1991) · BMJ · doi:10.1136/bmj.302.6776.560 · Cited by 484
An amino acid substitution in the human intestinal fatty acid binding protein is associated with increased fatty acid binding, increased fat oxidation, and insulin resistance.
Baier, L. J., Sacchettini, J. C., Knowler, W. C., Eads, J. C., Paolisso, G., Tataranni, P. A., Mochizuki, H., Bennett, P. H., Bogardus, C., & Procházka, M. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117778 · Cited by 371
Prevalence of coronary artery disease and its relationship to lipids in a selected population in South India
Mohan, V., Deepa, R., Rani, S. S., & Premalatha, G. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01415-2 · Cited by 365
Self-citation
Association of early-onset coronary heart disease in South Asian men with glucose intolerance and hyperinsulinemia.
McKeigue, P., Ferrie, J. E., Pierpoint, T., & Marmot, M. G. (1993) · Circulation · doi:10.1161/01.cir.87.1.152 · Cited by 361
Common genetic variation in the promoter of the human apo CIII gene abolishes regulation by insulin and may contribute to hypertriglyceridemia.
Li, W. W., Dammerman, M. M., Smith, J. D., Metzger, S., Breslow, J. L., & Leff, T. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118324 · Cited by 278
Remnant-like particle (RLP) cholesterol is an independent cardiovascular disease risk factor in women: results from the Framingham Heart Study
McNamara, J. R. (2001) · Atherosclerosis · doi:10.1016/s0021-9150(00)00484-6 · Cited by 278
Intra‐urban differences in the prevalence of the metabolic syndrome in southern India – the Chennai Urban Population Study (CUPS No. 4)
Mohan, V., Shanthirani, S., Deepa, R., Premalatha, G., Sastry, N. G., & Saroja, R. (2001) · Diabetic Medicine · doi:10.1046/j.1464-5491.2001.00421.x · Cited by 251
Self-citation
Non-obese (body mass index < 25 kg/m2) Asian Indians with normal waist circumference have high cardiovascular risk.
Vikram, N., Pandey, R., Misra, A., Sharma, R., Devi, J. R., & Khanna, N. (2003) · Nutrition (Burbank, Los Angeles County, Calif.) · doi:10.1016/s0899-9007(02)01083-3 · Cited by 224
Critical Evaluation of Adult Treatment Panel III Criteria in Identifying Insulin Resistance With Dyslipidemia
Liao, Y., Kwon, S., Shaughnessy, S., Wallace, P., Hutto, A., Jenkins, A. J., Klein, R. L., & Garvey, W. T. (2004) · Diabetes Care · doi:10.2337/diacare.27.4.978 · Cited by 218
Transcriptional regulation of the apoC-III gene by insulin in diabetic mice: correlation with changes in plasma triglyceride levels.
Chen, M., Breslow, J. L., Li, W., & Leff, T. (1994) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)39938-7 · Cited by 183
A Polymorphism in the Human Intestinal Fatty Acid Binding Protein Alters Fatty Acid Transport across Caco-2 Cells
Baier, L. J., Bogardus, C., & Sacchettini, J. C. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.18.10892 · Cited by 181
Apolipoprotein C-III, metabolic syndrome, and risk of coronary artery disease
Olivieri, O., Bassi, A., Stranieri, C., Trabetti, E., Martinelli, N., Pizzolo, F., Girelli, D., Friso, S., Pignatti, P. F., & Corrocher, R. (2003) · Journal of Lipid Research · doi:10.1194/jlr.m300253-jlr200 · Cited by 139
Linkage of Chromosomal Markers on 4q With a Putative Gene Determining Maximal Insulin Action in Pima Indians
Procházka, M., Lillioja, S., Tait, J. F., Knowler, W. C., Mott, D. M., Spraul, M., Bennett, P. H., & Bogardus, C. (1993) · Diabetes · doi:10.2337/diab.42.4.514 · Cited by 134
The Polymorphism at Codon 54 of the FABP2 Gene Increases Fat Absorption in Human Intestinal Explants
Levy, E. H., Ménard, D., DELVIN, E. E., Stan, S., Mitchell, G. A., Lambert, M. A., Ziv, E., Feoli‐Fonseca, J. C., & Seidman, E. G. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m105713200 · Cited by 122
Clustering of Cardiovascular Risk Factors in Urban Asian Indians
Ramachandran, A., Snehalatha, C., LATHA, E., Satyavani, K., & Viswanathan, V. (1998) · Diabetes Care · doi:10.2337/diacare.21.6.967 · Cited by 122
Postprandial Lipemic Response Is Modified by the Polymorphism at Codon 54 of the Fatty Acid–Binding Protein 2 Gene
Ågren, J. J., Valve, R., Vidgren, H. M., Laakso, M., & Uusitupa, M. I. J. (1998) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.18.10.1606 · Cited by 105
Linkage and Association Between Distinct Variants of the APOA1/C3/A4/A5 Gene Cluster and Familial Combined Hyperlipidemia
Eichenbaum‐Voline, S., Olivier, M., Jones, E. L., Naoumova, R. P., Jones, B., Gau, B. C., Patel, H., Seed, M., Betteridge, D. J., Galton, D. J., et al. (2003) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000099881.83261.d4 · Cited by 102
Fatty acid binding protein-2 gene variants and insulin resistance: gene and gene-environment interaction effects
Weiss, E. P., Brown, M. D., Shuldiner, A. R., & Hagberg, J. M. (2002) · Physiological Genomics · doi:10.1152/physiolgenomics.00070.2001 · Cited by 101
Common Genomic Variation in theAPOC3Promoter Associated With Variation in Plasma Lipoproteins
Hegele, R. A., Connelly, P. W., Hanley, A. J., Sun, F. Y., Harris, S. B., & Zinman, B. (1997) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.17.11.2753 · Cited by 75
ApoC-III gene polymorphisms and risk of coronary artery disease
Olivieri, O., Stranieri, C., Bassi, A., Zaia, B., Girelli, D., Pizzolo, F., Trabetti, E., Cheng, S., Grow, M. A., Pignatti, P. F., et al. (2002) · Journal of Lipid Research · doi:10.1194/jlr.m200145-jlr200 · Cited by 70
Codon-54 Polymorphism of the Fatty Acid-Binding Protein 2 Gene Is Associated with Elevation of Fasting and Postprandial Triglyceride in Type 2 Diabetes*
Georgopoulos, A., Aras, Ö., & Tsai, M. Y. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.9.6791 · Cited by 69
Self-citation
Endogenous Levels of Serum Estradiol and Sex Hormone Binding Globulin Determine Bone Mineral Density, Bone Remodeling, the Rate of Bone Loss, and Response to Treatment with Estrogen in Elderly Women
Rapuri, P. B., Gallagher, J. C., & Haynatzki, G. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0434 · Cited by 67
Type 2 diabetes mellitus: association study of five candidate genes in an Indian population of Guadeloupe, genetic contribution of FABP2 polymorphism.
Boullu-Sanchis, S., Leprêtre, F., Hédelin, G., Jp, D., Schaffer, P., Froguel, P., & Pinget, M. (1999) · PubMed · Cited by 65
Abdominal Obesity, Impaired Nonesterified Fatty Acid Suppression, and Insulin-Mediated Glucose Disposal Are Early Metabolic Abnormalities in Families With Premature Myocardial Infarction
Kooner, J. S., Baliga, R. R., Wilding, J. P. H., Crook, D., Packard, C. J., Banks, L. M., Peart, S., Aitman, T. J., & Scott, J. (1998) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.18.7.1021 · Cited by 61
Genetic determinants of plasma lipid response to dietary intervention: the role of theAPOA1/C3/A4gene cluster and theAPOEgene
Ordovás, J. M., & Schaefer, E. J. (2000) · British Journal Of Nutrition · doi:10.1017/s0007114500001069 · Cited by 61
Linkage of chromosomal markers on 4q with a putative gene determining maximal insulin action in Pima Indians
Procházka, M., Lillioja, S., Tait, J. F., et al. (1993) · Diabetes · doi:10.2337/diabetes.42.4.514 · Cited by 57
Insulin resistance alone does not explain the clustering of cardiovascular risk factors in southern India
Snehalatha, C., Sivasankari, S., Satyavani, K., Viswanathan, V., & Ramachandran, A. (2000) · Diabetic Medicine · doi:10.1046/j.1464-5491.2000.00239.x · Cited by 50
Gender related association between genetic variations of APOC-III gene and lipid and lipoprotein variables in northern France
Dallongeville, J., Meirhaeghe, A., Cottel, D., Fruchart, J., Amouyel, P., & Helbecque, N. (2000) · Atherosclerosis · doi:10.1016/s0021-9150(99)00362-7 · Cited by 48
Association of plasma lipids and apolipoproteins with the insulin response element in the apoC-III promoter region in familial combined hyperlipidemia
Groenendijk, M., Cantor, R. M., Blom, N. H. H. C., Rotter, J. I., de Bruin, T. W., & Dallinga‐Thie, G. M. (1999) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)33507-0 · Cited by 47
Cholesterol lipoproteins, triglycerides, rural-urban differences and prevalence of dyslipidaemia among males in Rajasthan.
Gupta, R., Prakash, H., & Kaul, V. (1997) · PubMed · Cited by 46
Variation in the FABP2 promoter alters transcriptional activity and is associated with body composition and plasma lipid levels
Damcott, C., Feingold, E., Moffett, S. P., Barmada, M. M., Marshall, J. A., Hamman, R. F., & Ferrell, R. E. (2003) · Human Genetics · doi:10.1007/s00439-003-0937-1 · Cited by 44
Hypertriglyceridemic mice transgenic for the human apolipoprotein C-III gene are neither insulin resistant nor hyperinsulinemic.
Reaven, G. M., Mondon, C. E., Chen, Y. I., & Breslow, J. L. (1994) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)39176-8 · Cited by 43
Lipoprotein distribution of apolipoprotein C-III and its relationship to the presence in plasma of triglyceride-rich remnant lipoproteins
Marcoux, C., Tremblay, M., Fredenrich, A., Davignon, J., & Cohn, J. S. (2001) · Metabolism · doi:10.1053/meta.2001.19452 · Cited by 41
A review of intestinal fatty acid binding protein gene variation and the plasma lipoprotein response to dietary components
Hegele, R. A. (1998) · Clinical Biochemistry · doi:10.1016/s0009-9120(98)00078-2 · Cited by 40
Non-obese hyperlipidemic Asian northern Indian males have adverse anthropometric profile.
Misra, A., Athiko, D., Sharma, R., Pandey, R. M., & Khanna, N. (2002) · PubMed · Cited by 37
Ischaemic heart disease and its risk factors in Singapore in comparison with other countries.
Hughes, K., Yeo, P. P., Lun, K. C., Sothy, S. P., Thai, A. C., Wang, K. W., & Cheah, J. S. (1989) · PubMed · Cited by 35
Lack of association of insulin resistance and carotid intimal medial thickness in non‐diabetic Asian Indian subjects
Snehalatha, C., Viswanathan, V., Mohan, R., Satyavani, K., Sivasankari, S., Megha, T., Radhika, S., & Ramachandran, A. (2001) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.226 · Cited by 34
Intestinal transcription and synthesis of apolipoprotein AI is regulated by five natural polymorphisms upstream of the apolipoprotein CIII gene.
Naganawa, S., Ginsberg, H. N., Glickman, R. M., & Ginsburg, G. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119363 · Cited by 28
Variation in the FABP2 promoter affects gene expression: implications for prior association studies
Baier, L. J., & Formanack, M. L. (2004) · Diabetologia · doi:10.1007/s00125-003-1289-z · Cited by 28
Codon-54 Polymorphism of the Fatty Acid-Binding Protein 2 Gene Is Associated with Elevation of Fasting and Postprandial Triglyceride in Type 2 Diabetes
Georgopoulos, A. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.9.3155 · Cited by 27
Self-citation
Effects of the FABP2 A54T Mutation on Triglyceride Metabolism of Viscerally Obese Men
Berthier, M., Couillard, C., Prud’homme, D., Nadeau, A., Bergeron, J., Tremblay, A., Després, J., & Vohl, M. (2001) · Obesity Research · doi:10.1038/oby.2001.91 · Cited by 26
Socioeconomic status and dyslipidaemia in a South Indian population: the Chennai Urban Population Study (CUPS 11).
Pradeepa, R., Deepa, R., Rani, S. S., Premalatha, G., Saroja, R., & Mohan, V. (2003) · PubMed · Cited by 24
Self-citation
Prevalence of the APOC3 promoter polymorphisms T-455C and C-482T in Asian-Indians
Miller, M. J., Rhyne, J., Khatta, M., Parekh, H., & Zeller, K. I. (2001) · The American Journal of Cardiology · doi:10.1016/s0002-9149(00)01322-9 · Cited by 17
Untitled work
Alberti (1998) · doi:10.1002/(sici)1096-9136(199807)15:7

Flagged first, then by citations

Sorted by citations

The Metabolic Syndrome
Grundy, S. M. (2010) · Springer eBooks · doi:10.1007/978-1-4419-5839-6_1 · Cited by 1,227
Multiple Chronic Conditions: Prevalence, Health Consequences, and Implications for Quality, Care Management, and Costs
Vogeli, C., Shields, A. E., Lee, T. A., Gibson, T. B., Marder, W. D., Weiss, K. B., & Blumenthal, D. (2007) · Journal of General Internal Medicine · doi:10.1007/s11606-007-0322-1 · Cited by 1,150
Apolipoprotein C3 gene variants in nonalcoholic fatty liver disease
Petersen, K. F., Dufour, S., Hariri, A., Nelson-Williams, C., Foo, J. N., Zhang, X.-M., Dziura, J., Lifton, R. P., & Shulman, G. I. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0907295 · Cited by 428
The Metabolic Syndrome in South Asians: Epidemiology, Determinants, and Prevention
Misra, A., & Khurana, L. (2009) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2009.0024 · Cited by 397
Nonalcoholic fatty liver disease
Krawczyk, M. J., Bonfrate, L., & Portincasa, P. (2010) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2010.08.005 · Cited by 193

See all 108

Authors: Guettier, J.-M., Georgopoulos, A., Tsai, M. Y., Radha, V., Shanthirani, S., Deepa, R., Gross, M., Rao, G., & Mohan, V.
Affiliations: University of Minnesota (US)
Madras Diabetes Research Foundation (IN)
Corresponding author: Georgopoulos, Angeliki
ORCID: Tsai, Michael Y.
Radha, Venkatesan
Rao, Gundu
Mohan, Viswanathan
Venue: The Journal of Clinical Endocrinology & Metabolism
Publisher: The Endocrine Society
Published: 2005-03
Volume: 90
Issue: 3
Pages: 1705-1711
ISSN: 0021-972X (ISSN-L)
1945-7197
DOI: 10.1210/jc.2004-1338
OpenAlex: W2085689054
Cited by: 108
References: 49
Citations by year: 2026: 1 · 2025: 3 · 2024: 5 · 2023: 2 · 2022: 2 · 2021: 2 · 2020: 3 · 2018: 5 · 2017: 7 · 2016: 5 · 2014: 11 · 2013: 3 · 2012: 1
FWCI: 6.58
Type: journal article
Language: en
Open access: closed
Locations: The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Nutrition, Genetics, and Disease
Keywords: fatty acid binding protein 2, apolipoprotein C-III, metabolic syndrome, dyslipidemia, Asian Indians, South Indian population, diabetes mellitus, cardiovascular disease, genetic susceptibility
MeSH terms: Adult, Aged, Apolipoproteins C, Carrier Proteins, Female, Gene Frequency, Humans, Hyperlipidemias, India, Male, Middle Aged, Polymorphism, Genetic, Promoter Regions, Genetic, Risk Factors, Prevalence, Genetic Predisposition to Disease, Metabolic Syndrome, Asian People, Fatty Acid-Binding Proteins, Apolipoprotein C-III

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Polymorphisms in the Fatty Acid-Binding Protein 2 and Apolipoprotein C-III Genes Are Associated with the Metabolic Syndrome and Dyslipidemia in a South Indian Population

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks